-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FtBAF8u4B5KhdONlMjirWvkOMRqNgRQ/0ttc4yVscxd9Av+rkEtU9YATW4/pyll4 3mwMB+0ElikmavMTLSUidg== 0001238916-04-000001.txt : 20040618 0001238916-04-000001.hdr.sgml : 20040618 20040618183742 ACCESSION NUMBER: 0001238916-04-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040618 FILED AS OF DATE: 20040618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUECHLER KENNETH F CENTRAL INDEX KEY: 0001238916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 04871432 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2004-06-18 0 0000834306 BIOSITE INC BSTE 0001238916 BUECHLER KENNETH F BIOSITE INCORPORATED 11030 ROSELLE STREET SAN DIEGO CA 92121 1 1 0 0 Senior VP, R&D Incentive Stock Option (right to buy) 44.18 2004-06-18 4 A 0 2263 0 A 2014-06-18 Common Stock 2263 2263 D Non-Qualified Stock Option (right to buy) 44.18 2004-06-18 4 A 0 32737 0 A 2014-06-18 Common Stock 32737 32737 D Option vests daily over a four-year period commencing on the date of grant, except that no options are exercisable for the first six months after the date of grant. By: Robyn Shutak For: Kenneth F. Buechler 2004-06-18 -----END PRIVACY-ENHANCED MESSAGE-----